Plain-English translation of NCT05046002 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at the Ottawa Heart Institute are building a registry to track people who experienced heart inflammation (myocarditis or pericarditis) within 42 days of receiving a COVID-19 vaccine. The study will look at past medical records and invite newly diagnosed patients to participate, collecting clinical information and blood samples to understand this condition better.
Although heart inflammation after COVID-19 vaccination is rare, doctors want to learn more about how often it occurs, who is most at risk, and what the long-term outcomes are so they can better recognize and treat patients who develop these symptoms.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have an initial clinic visit where researchers review your medical history and may collect blood samples. You'll return for a follow-up visit 4 to 12 weeks later. After that, the research team will contact you by phone at 6 months, 12 months, and then yearly for up to 4 years to check on your progress and complete quality-of-life questions. Some participants may also serve as comparison controls to help researchers understand the difference between vaccinated people with and without heart inflammation.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Canada